🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 44 of 78

  1. US 8609395

    Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8609716

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8604184

    Chemically programmable immunity

    Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8603978

    Use of muramyl dipeptide (MDP) for treating inflammation

    Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8603808

    Leishmania vaccine using sand fly salivary immunogen

    Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8603468

    Neutralization of HCV

    Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8603456

    Method of treating hair loss with compositions containing interleukin-1

    Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8603462

    Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction

    Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8597883

    Biomarkers for cancer-related fatigue and use thereof

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8597660

    Therapeutic approach to neurodegenerative disorders using a TFP5-peptide

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8597876

    Method of treating HIV infection

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8591889

    Human monoclonal antibodies specific for CD22

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8586055

    DNA immunization protocols

    Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8580944

    Suppressors of CpG oligonucleotides and methods of use

    Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8580927

    Engineered antibody constant domain molecules

    Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8575121

    Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8574468

    Benzo-fused heterocyclic chromophores for nonlinear optical devices

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8574853

    Monoclonal antibodies that neutralize anthrax toxins

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8574467

    Benzo-fused heterocyclic chromophores for nonlinear optical devices

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8575375

    Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8568977

    Compositions and methods for diagnosis and treatment of tumors

    Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8569028

    Method for encapsulation of microparticles

    Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8568739

    Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

    Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8568714

    Lys K endolysin is synergistic with lysostaphin against MRSA

    Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8569377

    Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel

    Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8563614

    Use of treprostinil to treat neuropathic diabetic foot ulcers

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8563599

    Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8556882

    Inducible interleukin-12

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8557844

    Substrate reduction therapy

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8557250

    Methods for preparing complex multivalent immunogenic conjugates

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8557789

    Method of treating inflammatory arthropathies with supressors of CPG oligonucleotides

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8557788

    Prevention of tissue ischemia and related compositions

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8551936

    Defensin-antigen fusion proteins

    Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8551536

    Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes

    Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8546524

    Smoothened polypeptides and methods of use

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8545888

    Tendon stem cells

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8546091

    AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy

    Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8541221

    Primate T-lymphotropic viruses

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8535890

    Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies

    Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8536148

    Disabling autophagy as a treatment for lysosomal storage diseases

    Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8536363

    Compounds and methods for delivery of prostacyclin analogs

    Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8535639

    Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging

    Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8530167

    Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8530626

    Methods to produce keratin elastomer

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8524239

    Photosensitizing antibody-fluorophore conjugates

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8524482

    Method and system for sampling and separating submicron-sized particles based on density and or size to detect the presence of a particular agent

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8524248

    Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8524247

    Rabies virus-based recombinant immunocontraceptive compositions and methods of use

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.